TABLE 1.
The clinical characteristics and pathological parameters of the two groups.
| CA (n = 32) | NCA (n = 27) | P | |
| Age (years) | 68.21 ± 1.04 | 65.00 ± 1.67 | 0.0516 |
| WBC (109/L) | 5.91 ± 0.43 | 6.87 ± 0.27 | 0.0594 |
| PSA (ng/μl) | 17.48 ± 2.60 | 31.72 ± 15.67 | 0.5866 |
| fPSA/PSA | 9.12 ± 1.87 | 13.57 ± 1.36 | 0.0679 |
| Gleason 6 | 43.75% (14/32) | ||
| Gleason 7 | 46.8% (15/32) | ||
| Gleason 8 | 9.4% (3/32) |
CA, prostate cancer; NCA, non-prostate cancer; PSA, prostate specific antigen; fPSA, free prostate specific antigen; Gleason, Prostate Gleason Grading system; WBC, white blood count.